• Info
  • Significant Ownership

Significant Ownership of Teoxane SA

Signature - Title
/s/ Patrice Calvayrac - Patrice Calvayrac/ Chief Financial Officer
Location
Geneva, Switzerland
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Teoxane SA.

Notify me when Teoxane SA files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Teoxane SA

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RVNC Revance Therapeutics, Inc. Common Stock, par value $0.001 per share 6.2% $32,335,404 6,550,800 0% Teoxane SA 30 Jan 2025

Schedules 13D/G Reported by Teoxane SA:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.